Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

116 – Increased Risk of Heart Failure With Preserved Ejection Fraction in South Africans With HIV

By Jimmy He PharmD, DScMarch 31, 2026

…and hypertension. Participants underwent a clinical assessment, echocardiography (Echo), and measure of b-type natriuretic peptide (BNP). Echo parameters defined structural abnormalities of the left atrium and left ventricle (LV), increased…

OPTIMIZING TESTING INCREASES YIELD IN HIV CASE FINDING IN 24 COUNTRIES, 2018–2019

By Jimmy He PharmD, DScApril 27, 2020

…among adults (1.4 overall) was greater among men (1.8) than women (1.1).  Contact testing had the highest yield (8.9%, 2018; 14.3%, 2019) and was the second largest contributor to overall…

Circulating Acyl-CoA-Binding Protein Abates T-Cell Function in People Living With HIV

By Jimmy He PharmD, DScMarch 6, 2024

…T-cell function in people living with HIV (PLWH) on antiretroviral therapy (ART). Methods: Plasma ACBP and cytokines were quantified by ELISA in 50 PLWH on effective ART (mean duration 14.7…

NK Cells During Acute HIV Infection Are Associated With Slow Disease Progression in Subtype A

By Jimmy He PharmD, DScMarch 6, 2024

…Protocol C’. Samples were collected at two weeks (median=18 days), 1-month (median= 32 days), and 3-month (median=91 days) post-HIV-1 infection. Multiparameter flow cytometry was used for phenotypic characterisation. ADCC responses…

PWH on ART and Tyrosine Kinase Inhibitors Show High Cytotoxic Activity Against HIV-1–Infected Cells

By Jimmy He PharmD, DScMarch 6, 2024

…as controls. Cell immunophenotyping was performed by flow cytometry. Cytotoxic activity was determined using NK-specific target cells K562 and HIV-1-infected TZM-bl. Cytokine release was measured after stimulation with HIV-1 peptide…

HIV Myeloid Derived Suppressor Cells Control Cytomegalovirus Inflammation by IL-27

By Enthusiast Inc MDFebruary 27, 2015

Background: CMV is associated with persistent inflammation in HIV-infected persons. Here, we studied the effect of HIV expanded myeloid derived suppressor cells (MDSCs) in controlling CMV specific inflammation. Methods: PBMCs…

HIV RECENT INFECTION IN SEXUAL AND GENDER MINORITIES IN BRAZIL AND PERU: IMPREP STUDY

By Jimmy He PharmD, DScMarch 24, 2023

…HIV testing services in Brazil (6 cities) and Peru (7 cities) from Jan/21-May/22. Inclusion criteria: 18+ years, cisgender men who have sex with men (cis-MSM), transgender women (TGW) and other…

CHARACTERISTICS OF HEALTH FACILITIES ASSOCIATED WITH LOW HIV VIRAL LOAD COVERAGE

By Jimmy He PharmD, DScApril 4, 2022

…with low VLT coverage (VLTC)), we analyzed data reported to the Monitoring, Evaluation, and Reporting (MER) System by 17 PEPFAR-supported sub-Saharan African countries in 2019 and 2020. We used ordinal…

EVALUATION OF HIV-SPECIFIC T CELL RESPONSE IN BEAT2 CLINICAL TRIAL

By Jimmy He PharmD, DScMarch 3, 2023

…vaccinal effect on HIV-specific T cells, increasing response frequencies and improving functional properties during bNAb-mediated suppression. Here, we evaluated whether such a vaccinal effect occurred in the BEAT2 clinical trial,…

HIV T-Cell Immunity Predicts Intact Proviral DNA Decline in People Treated During Acute Infection

By Jimmy He PharmD, DScMarch 6, 2024

…size and HIV specific immune responses in participants of the Netherlands Cohort Study on Acute HIV Infection (NOVA study), who initiated ART immediately after diagnosis of AHI. Methods: Participants in…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455
…5657585960…
61626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top